Lipid nanoparticles (LNPs) are gaining attention as effective drug delivery vehicles, especially since their successful use in the COVID-19 vaccines. …
Read Post
A central challenge with particle analysis in biotherapeutics is the wide size range of particles that may be present, including particles from the …
Read Post
While most imaging particle analyzers are equipped with black and white (monochrome) cameras for image acquisition, FlowCam 8100 instruments offer a …
Read Post
Subvisible particles in biotherapeutics represent critical quality attributes because they pose regulatory and potential product safety risks. …
Read Post
Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production. These particles must be …
Read Post